Northeast Pharmaceutical Group Co Ltd (000597) — Financial Flexibility Index
Northeast Pharmaceutical Group Co Ltd (000597) has a Financial Flexibility Index of 0.04x as of September 2025. Free cash flow of CN¥285.57 Million (operating CF CN¥274.09 Million minus capex CN¥11.48 Million) represents 0% of total liabilities (CN¥8.05 Billion). Also explore how fast is Northeast Pharmaceutical Group Co Ltd growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Northeast Pharmaceutical Group Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Northeast Pharmaceutical Group Co Ltd across 28 annual periods. Check asset allocation strategy of Northeast Pharmaceutical Group Co Ltd to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Northeast Pharmaceutical Group Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Northeast Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see Northeast Pharmaceutical Group Co Ltd (000597) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.17x | CN¥1.20 Billion | CN¥1.11 Billion | CN¥7.22 Billion | ▲ +61.2% |
| 2024 | 0.10x | CN¥918.19 Million | CN¥758.76 Million | CN¥8.88 Billion | ▲ +27.3% |
| 2023 | 0.08x | CN¥822.18 Million | CN¥586.75 Million | CN¥10.11 Billion | ▼ -45.3% |
| 2022 | 0.15x | CN¥1.35 Billion | CN¥1.11 Billion | CN¥9.10 Billion | ▲ +52.6% |
| 2021 | 0.10x | CN¥866.31 Million | CN¥746.51 Million | CN¥8.89 Billion | ▼ -19.3% |
| 2020 | 0.12x | CN¥971.30 Million | CN¥570.92 Million | CN¥8.04 Billion | ▲ +79.0% |
| 2019 | 0.07x | CN¥581.77 Million | CN¥352.60 Million | CN¥8.62 Billion | ▼ -35.6% |
| 2018 | 0.10x | CN¥850.83 Million | CN¥285.09 Million | CN¥8.13 Billion | ▲ +642.6% |
| 2017 | 0.01x | CN¥113.43 Million | CN¥-301.20 Million | CN¥8.05 Billion | ▼ -81.5% |
| 2016 | 0.08x | CN¥561.52 Million | CN¥384.51 Million | CN¥7.36 Billion | ▲ +7.7% |
| 2015 | 0.07x | CN¥445.74 Million | CN¥99.70 Million | CN¥6.29 Billion | ▼ -28.9% |
| 2014 | 0.10x | CN¥579.26 Million | CN¥46.99 Million | CN¥5.81 Billion | ▲ +219.8% |
| 2013 | 0.03x | CN¥185.64 Million | CN¥-266.38 Million | CN¥5.96 Billion | ▼ -50.1% |
| 2012 | 0.06x | CN¥264.99 Million | CN¥86.09 Million | CN¥4.24 Billion | ▲ +36.9% |
| 2011 | 0.05x | CN¥188.33 Million | CN¥-233.32 Million | CN¥4.13 Billion | ▼ -77.9% |
| 2010 | 0.21x | CN¥729.89 Million | CN¥255.96 Million | CN¥3.54 Billion | ▼ -43.9% |
| 2009 | 0.37x | CN¥1.48 Billion | CN¥615.91 Million | CN¥4.03 Billion | ▼ -13.0% |
| 2008 | 0.42x | CN¥1.07 Billion | CN¥709.03 Million | CN¥2.53 Billion | ▲ +218.9% |
| 2007 | 0.13x | CN¥286.34 Million | CN¥198.56 Million | CN¥2.16 Billion | ▲ +391.5% |
| 2006 | -0.05x | CN¥-58.16 Million | CN¥-106.00 Million | CN¥1.28 Billion | ▼ -129.5% |
| 2005 | 0.15x | CN¥215.06 Million | CN¥111.40 Million | CN¥1.40 Billion | ▼ -12.4% |
| 2004 | 0.18x | CN¥272.20 Million | CN¥211.06 Million | CN¥1.55 Billion | ▼ -8.7% |
| 2003 | 0.19x | CN¥317.54 Million | CN¥230.08 Million | CN¥1.65 Billion | ▲ +77.8% |
| 2002 | 0.11x | CN¥195.48 Million | CN¥157.41 Million | CN¥1.81 Billion | ▲ +61.5% |
| 2001 | 0.07x | CN¥125.42 Million | CN¥78.84 Million | CN¥1.87 Billion | ▲ +144.5% |
| 2000 | 0.03x | CN¥48.31 Million | CN¥36.13 Million | CN¥1.76 Billion | ▼ -25.9% |
| 1999 | 0.04x | CN¥64.03 Million | CN¥54.62 Million | CN¥1.73 Billion | ▲ +324.9% |
| 1998 | 0.01x | CN¥13.84 Million | CN¥-7.59 Million | CN¥1.59 Billion | — |